Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company has developed the only FDA-cleared surgical robotic system designed to enhance surgeon implant placement for total knee replacements. Over 4,500 procedures have been performed in the U.S. using their technology. Their systems are designed to improve patient satisfaction, reduce hospital costs, and provide a customized fit without requiring MRI or x-rays.
Recent milestones include commercial deployment of the OMNIBotics Active Spacer system for improved soft tissue balancing during knee replacement surgeries.
Strategic partnerships include collaboration with Cell Microsystems to bring advanced cellular analysis solutions to North America.
No drug development pipeline; focus on medical devices.
Pipeline breadth: 2 main commercialized platforms/devices
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omnilife.